These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 12105090

  • 1. Behavioral consequences of methamphetamine-induced neurotoxicity in mice: relevance to the psychopathology of methamphetamine addiction.
    Itzhak Y, Ali SF.
    Ann N Y Acad Sci; 2002 Jun; 965():127-35. PubMed ID: 12105090
    [Abstract] [Full Text] [Related]

  • 2. Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine.
    Itzhak Y, Martin JL, Ali SF.
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1177-83. PubMed ID: 12452543
    [Abstract] [Full Text] [Related]

  • 3. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.
    Itzhak Y, Gandia C, Huang PL, Ali SF.
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1040-7. PubMed ID: 9495865
    [Abstract] [Full Text] [Related]

  • 4. The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo.
    Itzhak Y, Ali SF.
    J Neurochem; 1996 Oct; 67(4):1770-3. PubMed ID: 8858965
    [Abstract] [Full Text] [Related]

  • 5. Effect of melatonin on methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization.
    Itzhak Y, Martin JL, Black MD, Ali SF.
    Neuropharmacology; 1998 Jun; 37(6):781-91. PubMed ID: 9707292
    [Abstract] [Full Text] [Related]

  • 6. Methamphetamine- and 1-methyl-4-phenyl- 1,2,3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice.
    Itzhak Y, Martin JL, Ali SF.
    Synapse; 1999 Dec 15; 34(4):305-12. PubMed ID: 10529724
    [Abstract] [Full Text] [Related]

  • 7. Mithramycin protects against dopaminergic neurotoxicity in the mouse brain after administration of methamphetamine.
    Hagiwara H, Iyo M, Hashimoto K.
    Brain Res; 2009 Dec 08; 1301():189-96. PubMed ID: 19748494
    [Abstract] [Full Text] [Related]

  • 8. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
    Killinger BA, Moszczynska A.
    J Neurochem; 2016 Feb 08; 136(3):510-25. PubMed ID: 26465779
    [Abstract] [Full Text] [Related]

  • 9. Protective effects of cholecystokinin-8 on methamphetamine-induced behavioral changes and dopaminergic neurodegeneration in mice.
    Gou H, Wen D, Ma C, Li M, Li Y, Zhang W, Liu L, Cong B.
    Behav Brain Res; 2015 Apr 15; 283():87-96. PubMed ID: 25629941
    [Abstract] [Full Text] [Related]

  • 10. Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity.
    Xie T, McCann UD, Kim S, Yuan J, Ricaurte GA.
    J Neurosci; 2000 Oct 15; 20(20):7838-45. PubMed ID: 11027249
    [Abstract] [Full Text] [Related]

  • 11. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.
    Anneken JH, Angoa-Pérez M, Kuhn DM.
    J Neurochem; 2015 Apr 15; 133(2):211-22. PubMed ID: 25626880
    [Abstract] [Full Text] [Related]

  • 12. Antagonists of the neurokinin-1 or dopamine D1 receptors confer protection from methamphetamine on dopamine terminals of the mouse striatum.
    Angulo JA, Angulo N, Yu J.
    Ann N Y Acad Sci; 2004 Oct 15; 1025():171-80. PubMed ID: 15542715
    [Abstract] [Full Text] [Related]

  • 13. Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure.
    Miller DB, O'Callaghan JP, Ali SF.
    Ann N Y Acad Sci; 2000 Sep 15; 914():194-207. PubMed ID: 11085321
    [Abstract] [Full Text] [Related]

  • 14. Long-term methamphetamine-induced decreases of [(11)C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey.
    Melega WP, Lacan G, Desalles AA, Phelps ME.
    Synapse; 2000 Mar 15; 35(4):243-9. PubMed ID: 10657033
    [Abstract] [Full Text] [Related]

  • 15. Comparison between the role of the neuronal and inducible nitric oxide synthase in methamphetamine-induced neurotoxicity and sensitization.
    Itzhak Y, Martin JL, Ali SF.
    Ann N Y Acad Sci; 2000 Sep 15; 914():104-11. PubMed ID: 11085313
    [Abstract] [Full Text] [Related]

  • 16. Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration : early loss of TH in striosomes after methamphetamine.
    Granado N, Ares-Santos S, O'Shea E, Vicario-Abejón C, Colado MI, Moratalla R.
    Neurotox Res; 2010 Jul 15; 18(1):48-58. PubMed ID: 19760475
    [Abstract] [Full Text] [Related]

  • 17. Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists.
    Achat-Mendes C, Anderson KL, Itzhak Y.
    Neuropsychopharmacology; 2007 Mar 15; 32(3):531-41. PubMed ID: 16760923
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence.
    Baumann MH, Phillips JM, Ayestas MA, Ali SF, Rice KC, Rothman RB.
    Ann N Y Acad Sci; 2002 Jun 15; 965():92-108. PubMed ID: 12105088
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.